We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GES
1951
DELISTED
Guess Inc
GES
$1.57M ﹤0.01%
69,630
+28,040
+67% +$635K
TSLX icon
1952
Sixth Street Specialty
TSLX
$1.78B
$1.57M ﹤0.01%
77,137
+23,095
+43% +$452K
AMU
1953
DELISTED
ETRACS Alerian MLP Index ETN
AMU
$1.57M ﹤0.01%
91,170
-14,957
-14% -$263K
PMO
1954
Franklin Municipal Opportunities Trust
PMO
$285M
$1.57M ﹤0.01%
137,509
+17,653
+15% +$205K
AG icon
1955
First Majestic Silver
AG
$9.35B
$1.56M ﹤0.01%
275,084
+37,993
+16% +$235K
PPBI
1956
DELISTED
Pacific Premier Bancorp
PPBI
$1.56M ﹤0.01%
41,934
-5,625
-12% -$215K
CCJ icon
1957
Cameco
CCJ
$43B
$1.56M ﹤0.01%
136,669
-2,278
-2% -$24K
ARKG icon
1958
ARK Genomic Revolution ETF
ARKG
$1.79B
$1.55M ﹤0.01%
46,435
+25,193
+119% +$797K
FDRR icon
1959
Fidelity Dividend ETF for Rising Rates
FDRR
$757M
$1.55M ﹤0.01%
+47,902
New +$1.52M
RRX icon
1960
Regal Rexnord
RRX
$11.5B
$1.55M ﹤0.01%
18,801
+561
+3% +$46.6K
KMI.PRA
1961
DELISTED
Kinder Morgan, Inc.
KMI.PRA
$1.55M ﹤0.01%
46,622
+6,122
+15% +$207K
VVC
1962
DELISTED
Vectren Corporation
VVC
$1.55M ﹤0.01%
21,654
+4,879
+29% +$348K
KT icon
1963
KT
KT
$8.83B
$1.54M ﹤0.01%
104,003
+397
+0.4% +$5.43K
RRC icon
1964
Range Resources
RRC
$9.5B
$1.54M ﹤0.01%
90,805
-47,289
-34% -$759K
LBTYA icon
1965
Liberty Global Class A
LBTYA
$3.48B
$1.54M ﹤0.01%
53,306
+37,977
+248% +$1.06M
WSBC icon
1966
WesBanco
WSBC
$4.05B
$1.54M ﹤0.01%
34,593
-118
-0.3% -$5.64K
SLF icon
1967
Sun Life Financial
SLF
$44.6B
$1.54M ﹤0.01%
38,671
+30,742
+388% +$1.23M
IEO icon
1968
iShares US Oil & Gas Exploration & Production ETF
IEO
$585M
$1.54M ﹤0.01%
20,231
+2,305
+13% +$171K
ITCI
1969
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.54M ﹤0.01%
70,800
+6,650
+10% +$139K
TOL icon
1970
Toll Brothers
TOL
$14.3B
$1.53M ﹤0.01%
46,448
+14,992
+48% +$543K
EVV
1971
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$1.53M ﹤0.01%
120,814
-1,129
-0.9% -$14.3K
SLP icon
1972
Simulations Plus
SLP
$370M
$1.53M ﹤0.01%
75,816
+26,201
+53% +$512K
IGR
1973
CBRE Global Real Estate Income Fund
IGR
$702M
$1.53M ﹤0.01%
209,626
+65,147
+45% +$488K
LAUR icon
1974
Laureate Education
LAUR
$5.05B
$1.53M ﹤0.01%
99,118
+3,903
+4% +$60.1K
MIDD icon
1975
Middleby
MIDD
$5.43B
$1.53M ﹤0.01%
11,831
-32
-0.3% -$3.65K

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.